Search - tctmd.com

Displaying 681 - 700 of 1782

Sort: Relevancy | Date

Presentation TCT 2019

SSO2 Therapy: Case Study

Presenter: Richard Schatz

September 26, 2019

Presentation TCT 2019

SSO2 Therapy: Clinical Evidence and Outcomes

Presenter: Gregg Stone

September 26, 2019

Presentation TCT 2019

SuperSaturated Oxygen Therapy: Background and Mechanism of Action

Presenter: James Spears

September 26, 2019

Presentation TCT 2019

Failed Therapeutic Approaches (Drugs and Devices) to Reduce Infarct Size

Presenter: E. Magnus Ohman

September 26, 2019

Presentation TCT 2019

Importance of Infarct Size and Microvascular Obstruction in STEMI

Presenter: Suzanne de Waha

September 26, 2019

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat This Patient?

Presenter: Chaim Lotan

September 25, 2019

Presentation TCT 2019

How I Would Treat This Case

Presenter: Mohamed Abed Bouraghda

September 25, 2019

Presentation TCT 2019

How I Would Treat This Case

Presenter: Khaled Al-Shaibi

September 25, 2019

Presentation TCT 2019

Case Introduction

Presenter: Chaim Lotan

September 25, 2019

Presentation TCT 2019

Case Example: A Complex STEMI

Presenter: Bimmer Claessen

September 25, 2019

Presentation TCT 2019

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

Presenter: Gregory Serrao

September 25, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Daily News

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

Todd Neale

September 19, 2019

News Daily News

Post-MI Mechanical Complications Infrequent but Deadly

Todd Neale

September 16, 2019

News Conference News ESC 2019

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

Caitlin E. Cox

September 10, 2019

News Conference News ESC 2019

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

Yael L. Maxwell

September 10, 2019

News Conference News ESC 2019

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

L.A. McKeown

September 09, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Conference News ESC 2019

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

Shelley Wood

September 04, 2019

Advertisement

SSO2 Therapy: Case Study

SSO2 Therapy: Clinical Evidence and Outcomes

SuperSaturated Oxygen Therapy: Background and Mechanism of Action

Failed Therapeutic Approaches (Drugs and Devices) to Reduce Infarct Size

Importance of Infarct Size and Microvascular Obstruction in STEMI

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Case Resolution: How Did I Treat This Patient?

How I Would Treat This Case

How I Would Treat This Case

Case Introduction

Case Example: A Complex STEMI

Acute Coronary Syndromes: Treatment of NSTE-ACS and STEMI

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

CMR May Help Evaluate Nonculprit Lesions in STEMI Patients

Post-MI Mechanical Complications Infrequent but Deadly

BIOSTEMI: Ultrathin-Strut Orsiro Superior to Xience for 1-Year TLF After Primary PCI

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

TRANSIENT: Treatment Timing Inconsequential When STEMI Resolves Before Revascularization

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Stopped Early, DAPA Offers Insight on ICD Timing After STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content